Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells

Tiejun Song1,1, Lei Yan2,1, Kerui Cai2

  • 1Department of Clinical Laboratory, The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang 157011, Heilongjiang, China.

Abstract

Insights

Drug resistance is a problem in cancer treatment. Inhibiting long non-coding RNA PVT1 (lncRNA PVT1) in glioma cells can overcome paclitaxel resistance, increasing cell death and reducing proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Drug resistance is a significant challenge in clinical cancer therapy.
  • Aberrant expression of long non-coding RNAs (lncRNAs) is implicated in various cancers, including glioma.
  • The role of specific lncRNAs, such as PVT1, in mediating drug resistance in glioma requires further investigation.

Purpose of the Study:

  • To investigate the function of the long non-coding RNA PVT1 (lncRNA PVT1) in paclitaxel-resistant human glioma cells.
  • To determine if targeting lncRNA PVT1 can overcome drug resistance in glioma treatment.

Main Methods:

  • Paclitaxel-resistant glioma cells (SHG-44 RE) were established and compared to parent cells (SHG-44).
  • Microarray analysis identified aberrantly expressed lncRNAs, with qRT-PCR validating lncRNA PVT1 overexpression in resistant cells.
  • Cell viability and apoptosis were assessed using MTT assays and flow cytometry after manipulating lncRNA PVT1 expression.

Main Results:

  • Long non-coding RNA PVT1 (lncRNA PVT1) was found to be significantly overexpressed in paclitaxel-resistant glioma cells (SHG-44 RE) compared to their sensitive counterparts (SHG-44).
  • Down-regulation of lncRNA PVT1 in SHG-44 RE cells led to decreased cell viability and increased apoptosis following paclitaxel treatment.
  • These findings indicate that inhibiting lncRNA PVT1 enhances the sensitivity of human glioma cells to paclitaxel.

Conclusions:

  • Down-regulation of lncRNA PVT1 can enhance chemosensitivity to paclitaxel, induce apoptosis, and inhibit proliferation in glioma cells.
  • Targeting lncRNA PVT1 presents a potential strategy to overcome paclitaxel resistance in clinical cancer medicine.
  • Further research into lncRNA PVT1's role could lead to improved therapeutic approaches for glioma patients experiencing drug resistance.

Related Concept Videos

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.1K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K
RNA Structure01:23

RNA Structure

Overview
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
79.1K